# Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis

> **NCT00043264** · PHASE2 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 40 (—)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Rifampin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00043264
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043264, "Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00043264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*